1
820
Helvetica Chimica Acta – Vol. 93 (2010)
subjected to CC (SiO ; PE/AcOEt gradient 10 :1 ! 3 :1) to give inophyllum A (250.6 mg), calophyllolide
2
(
564.0 mg), inophyllum C (80.3 mg), 8 (123.0 mg), and Fr. D1 (13.3 mg). Fr. D1 was subjected to
HPTLC (hexane/AcOEt 3 :1) to give 4 (7.2 mg) and 5 (1.2 mg). Fr. C (1.05 g) was subjected to prep.
HPLC (MeOH/H O gradient 3 :1 ! 20 :1) to give isocalophyllic acid (132.5 mg), calophyllic acid
2
(
(
120.8 mg), inophyllum E (110.6 mg), and Fr. C1 (80.3 mg). Fr. C1 was subjected to prep. HPLC
MeCN/H O 19 :1) to give 6 (32.1 mg) and 7 (34.8 mg). Fr. B (3.80 g) was passed through a Sephadex
2
LH-20 column with 95% EtOH to give astragalin (3.06 g).
1
2-O-Butylinophyllum D (¼(10R,11S,12R)-12-Butoxy-11,12-dihydro-6,6,10,11-tetramethyl-4-phe-
2
0
nyl-2H,6H,10H-dipyrano[2,3-f :2’,3’-h]chromen-2-one; 1). Yellow amorphous powder. [a] ¼ þ23.0
D
(
1
c ¼ 0.07, CHCl ). UV (MeOH): 236, 278, 286, 332 nm. IR (KBr): 3438, 2931, 1739 (C¼O), 1637, 1587,
3
1
13
463, 1373, 1315, 1181, 1128,1085, 865, 748, 702. H- and C-NMR: Tables 1 and 2, resp. EI-MS: 460 (24,
þ
þ
M ), 445 (100), 417 (4), 387 (57, [M ꢀ C H OH] ), 371 (25), 333 (20), 149 (25). HR-EI-MS: 460.2254
4
9
þ
þ
5
(
M , C H O ; calc. 460.2250).
29 32
1
2-O-Ethylinophyllum D (¼(10R,11S,12R)-12-Ethoxy-11,12-dihydro-6,6,10,11-tetramethyl-4-phe-
2
0
nyl-2H,6H,10H-dipyrano[2,3-f :2’,3’-h]chromen-2-one; 2). Yellow amorphous powder. [a] ¼ ꢀ4.0
D
(
1
c ¼ 0.075, CHCl ). UV (MeOH): 236, 279, 285, 335. IR (KBr): 3435, 2971, 1736 (C¼O), 1637, 1587,
3
1
13
444, 1373, 1315, 1181, 1141, 1128, 1078, 1012, 858, 748, 702. H- and C-NMR: Tables 1 and 2, resp. EI-
þ
þ
þ
MS: 432 (20, M ), 417 (100), 403 (65, [M ꢀ C H ] ), 387 (21, [M ꢀ C H OH] ), 371 (25), 333 (16), 178
2
5
2
5
þ
þ
5
(
6). HR-EI-MS: 432.1944 (M , C H O ; calc. 432.1937).
27 28
Inophyllum H (¼(2R*,3R*,4R*)-3,4,10,10a-Tetrahydro-4-hydroxy-2,3,10,10-tetramethyl-8-phenyl-
H,6H,9aH-cyclopropa[4,5]furo[2,3-f]pyrano[2,3-h]chromen-6-one; 3). White amorphous powder.
2
[
1
4
20
a] ¼ þ136.6 (c ¼ 0.20, CHCl ). UV (CHCl ): 226, 256, 337. IR (KBr): 3426 (OH), 2971, 1708, 1604,
D
3
3
1
13
568, 1421, 1384, 1324, 1228, 1139, 1099, 1031, 748, 700. H- and C-NMR: Tables 1 and 2, resp. EI-MS:
þ
þ
04 (15, M ), 389 (100), 371 (65), 334 (44), 317 (19), 178 (8), 164 (4), 84 (12). HR-EI-MS: 404.1630 (M ,
þ
C H O ; calc. 404.1624).
25
24
5
Inophyllum
I
(¼10,10a-Dihydro-2,3,10,10-tetramethyl-8-phenyl-2H,6H,9aH-cyclopropa[4,5]-
20
furo[2,3-f]pyrano[2,3-h]chromen-6-one; 4). White amorphous powder. [a] ¼ ꢀ4.0 (c ¼ 0.005, CHCl ).
D
3
UV (MeOH): 228, 255, 338. IR (KBr): 3404 (OH), 2924, 1701, 1631, 1572, 1458, 1419, 1363, 1198, 1074,
þ
1
1
020, 903, 764, 698. EI-MS: 386 (21, M ), 371 (100), 333 (41), 317 (3), 178 (5), 149 (6). H- and
C-NMR: Tables 1 and 2, resp. HR-EI-MS: 386.1502 (M , C H O ; calc. 386.1518).
1
3
þ
þ
25
22
4
2
7-[(E)-Coumaroyloxy]friedelin-28-carboxylic Acid (¼(4aS,6aR,6bS,8aS,9R,12aS,12bS,14aR,
1
4bS)-14a-({[(2E)-3-(4-Hydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6a,8a,9,12b-hexamethyl-10-oxo-
2
0
icosahydropicene-4a(2H)-carboxylic Acid; 5). White amorphous powder. [a] ¼ þ49.4 (c ¼ 0.37,
D
CHCl ). UV (MeOH): 315, 231, 210. IR (KBr): 3415, 2948, 1701, 1604, 1514, 1451, 1392, 1267, 1169,
3
1
13
þ
þ
8
4
31, 733. H- and C-NMR: Tables 3. ESI-MS: 619 ([M þ H] ). EI-MS: 618 (8, M ), 455 (4), 454 (10),
þ þ
41 (12), 409 (6), 395 (45), 164 (40), 163 (9), 147 (100), 119 (31). HR-EI-MS: 618.3925 (M , C H O ;
39 54 6
calc. 618.3920).
2
7-[(Z)-Coumaroyloxy]friedelin-28-carboxylic Acid (¼(4aS,6aR,6bS,8aS,9R,12aS,12bS,14aR,
1
4bS)-14a-({[(2Z)-3-(4-Hydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6a,8a,9,12b-hexamethyl-10-oxo-
2
0
icosahydropicene-4a(2H)-carboxylic Acid; 6). White amorphous powder. [a] ¼ ꢀ17.0 (c ¼ 0.05,
D
CHCl ). UV (MeOH): 310, 228, 212. IR (KBr): 3392, 2949, 2870, 1701, 1604, 1514, 1450, 1390, 1168,
3
þ
1
13
þ
9
(
6
83, 841, 733. ESI-MS: 619 ([M þ H] ). H- and C-NMR: Tables 3. EI-MS: 618 (14, M ), 454 (9), 441
20), 409 (17), 396 (15), 395 (48), 189 (17), 177 (25), 164 (12), 163 (17), 147 (100), 119 (19). HR-EI-MS:
þ
þ
6
18.3928 (M , C H O ; calc. 618.3920).
39 54
Apetalolide (¼ 5-Methoxy-8,8-dimethyl-10-[(2E)-2-methylbut-2-enoyl]-4-phenyl-2H,8H-pyrano[3,2-
g]chromen-2-one; 7). White amorphous powder. UV (MeOH): 352, 272, 237. IR (KBr): 3435, 2927, 2852,
þ
1
3
737, 1641, 1577, 1463, 1344, 1135, 1016, 864, 749, 700. EI-MS: 416 (19, M ), 402 (24), 401 (100), 389 (49),
þ
þ
71 (74), 333 (27), 317 (5), 178 (4), 77 (5). HR-EI-MS: 416.1628 (M , C H O ; calc. 416.1623).
26
24
5
Preparation of the (R)- and (S)-MTPA Esters of Inophyllum D (8). A soln. of (R)-a-methoxy-a-
trifluoromethyl)phenylacetic acid ((R)-MTPA) chloride (4.0 mg in 80 ml of benzene) was added to a
(
soln. of 8 (4 mg) in dry benzene (3 ml). A 0.05-mg aliquot of 4-(dimethylamino)pyridine (DMAP) and
Et N (15 ml) were added, and the mixture was refluxed. After 3 h, a second portion of (R)-MTPA
3
chloride (4.0 mg) was added, and the mixture was refluxed for an additional 2 h. When the mixture was